Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Volumn 11, Issue 13 Pt 2, 2005, Pages

  Vokes, Everett E ^a   Crawford, Jeffrey ^a   Bogart, Jeffrey ^a   Socinski, Mark A ^a   Clamon, Gerald ^a   Green, Mark R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH STATUS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

MLCS; MLOWN;

EID: 24944508087     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.ccr-05-9008     Document Type: Review

References (54)